Cell And Gene Therapy Analytical Services

Cell and gene therapies advancing toward clinical trials require robust analytical testing to ensure product quality and safety. However, these processes present a significant bottleneck for manufacturers at the moment. Utilizing a robust technical panel is essential to maintain a competitive edge and maximize therapeutic efficacy.

Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, reviews how comprehensive analytical services that cover a wide range of project needs can help keep a project on track.